Business Description
PELL Bio-Med Technology Co Ltd
ISIN : TW0006949001
Description
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell).
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.03 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.5 | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 10.42 | |||||
| Beneish M-Score | -2.48 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.79 | |||||
| 9-Day RSI | 40.68 | |||||
| 14-Day RSI | 38.73 | |||||
| 6-1 Month Momentum % | -37.79 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 12.01 | |||||
| Quick Ratio | 11.95 | |||||
| Cash Ratio | 11.83 | |||||
| Days Inventory | 49.14 | |||||
| Days Sales Outstanding | 98.47 | |||||
| Days Payable | 81.7 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -19.28 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -67.47 | |||||
| Operating Margin % | -2227.04 | |||||
| Net Margin % | -2097.55 | |||||
| FCF Margin % | -1991.07 | |||||
| ROE % | -32.92 | |||||
| ROA % | -26.14 | |||||
| ROIC % | -116.77 | |||||
| ROC (Joel Greenblatt) % | -131.04 | |||||
| ROCE % | -28.39 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 247.75 | |||||
| PB Ratio | 3.72 | |||||
| Price-to-Tangible-Book | 3.72 | |||||
| EV-to-EBIT | -9.78 | |||||
| EV-to-EBITDA | -11.1 | |||||
| EV-to-Revenue | 206.04 | |||||
| EV-to-FCF | -9.85 | |||||
| Price-to-Net-Current-Asset-Value | 5.42 | |||||
| Price-to-Net-Cash | 5.54 | |||||
| Earnings Yield (Greenblatt) % | -10.24 | |||||
| FCF Yield % | -7.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PELL Bio-Med Technology Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 18.412 | ||
| EPS (TTM) (NT$) | -6.99 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 38.73 | ||
| 14-Day ATR (NT$) | 2.387451 | ||
| 20-Day SMA (NT$) | 84.175 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (NT$) | 70.6 - 178.5 | ||
| Shares Outstanding (Mil) | 57.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PELL Bio-Med Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PELL Bio-Med Technology Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PELL Bio-Med Technology Co Ltd Frequently Asked Questions
What is PELL Bio-Med Technology Co Ltd(TPE:6949)'s stock price today?
The current price of TPE:6949 is NT$82.50. The 52 week high of TPE:6949 is NT$178.50 and 52 week low is NT$70.60.
When is next earnings date of PELL Bio-Med Technology Co Ltd(TPE:6949)?
The next earnings date of PELL Bio-Med Technology Co Ltd(TPE:6949) is .
Does PELL Bio-Med Technology Co Ltd(TPE:6949) pay dividends? If so, how much?
PELL Bio-Med Technology Co Ltd(TPE:6949) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers